GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (FRA:NZM2) » Definitions » Margin of Safety % (DCF Dividends Based)

Novonesis (Novozymes) B (FRA:NZM2) Margin of Safety % (DCF Dividends Based) : -60.05% (As of Dec. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Novonesis (Novozymes) B Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-12-14), Novonesis (Novozymes) B's Predictability Rank is 4.5-Stars. Novonesis (Novozymes) B's intrinsic value calculated from the Discounted Dividend model is €22.20 and current share price is €55.68. Consequently,

Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is -60.05%.


Competitive Comparison of Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based)

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) falls into.



Novonesis (Novozymes) B Margin of Safety % (DCF Dividends Based) Calculation

Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(34.79-55.68)/34.79
=-60.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.


Novonesis (Novozymes) B Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Industry
Traded in Other Exchanges
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines